Does ERLOTINIB Cause Decreased appetite? 998 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 998 reports of Decreased appetite have been filed in association with ERLOTINIB (Erlotinib). This represents 4.4% of all adverse event reports for ERLOTINIB.
998
Reports of Decreased appetite with ERLOTINIB
4.4%
of all ERLOTINIB reports
249
Deaths
234
Hospitalizations
How Dangerous Is Decreased appetite From ERLOTINIB?
Of the 998 reports, 249 (24.9%) resulted in death, 234 (23.4%) required hospitalization, and 11 (1.1%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for ERLOTINIB.
What Other Side Effects Does ERLOTINIB Cause?
Death (5,000)
Rash (4,648)
Diarrhoea (3,448)
Fatigue (1,548)
Nausea (1,366)
Drug ineffective (1,207)
Off label use (1,190)
Malignant neoplasm progression (954)
Dry skin (953)
Disease progression (910)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ERLOTINIB Alternatives Have Lower Decreased appetite Risk?
ERLOTINIB vs ERTAPENEM
ERLOTINIB vs ERTUGLIFLOZIN PIDOLATE
ERLOTINIB vs ERYTHROMYCIN
ERLOTINIB vs ERYTHROMYCIN ETHYLSUCCINATE
ERLOTINIB vs ERYTHROMYCIN LACTOBIONATE